KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Net Margin (2016 - 2025)

Historic Net Margin for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to 7.6%.

  • Quest Diagnostics' Net Margin fell 4000.0% to 7.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.78%, marking a year-over-year increase of 1800.0%. This contributed to the annual value of 8.78% for FY2024, which is 3700.0% down from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Net Margin is 7.6%, which was down 4000.0% from 9.05% recorded in Q2 2025.
  • Quest Diagnostics' Net Margin's 5-year high stood at 23.49% during Q2 2021, with a 5-year trough of 3.26% in Q4 2022.
  • In the last 5 years, Quest Diagnostics' Net Margin had a median value of 8.41% in 2023 and averaged 9.86%.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 262300bps in 2021, then tumbled by -150500bps in 2022.
  • Quest Diagnostics' Net Margin (Quarter) stood at 12.72% in 2021, then crashed by -74bps to 3.26% in 2022, then soared by 117bps to 7.08% in 2023, then rose by 6bps to 7.48% in 2024, then increased by 2bps to 7.6% in 2025.
  • Its last three reported values are 7.6% in Q3 2025, 9.05% for Q2 2025, and 6.94% during Q1 2025.